Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4–ALK Fusion Gene

Tsuyoshi Takahashi(Kyoto University), Makoto Sonobe(Kyoto University), Masashi Kobayashi(Kyoto University), Akihiko Yoshizawa(Kyoto University), Toshi Menju(Kyoto University), Ei Nakayama(Kyoto University), Nobuya Mino(Kyoto University), Shotaro Iwakiri(Kyoto University), Kiyoshi Sato(Kyoto University), Ryo Miyahara(Kyoto University), K. Okubo(Kyoto University), Toshiaki Manabe(Kyoto University), Hiroshi Date(Kyoto University)
Annals of Surgical Oncology
November 20, 2009
10.1245/s10434-009-0808-7
Cited by 323

Abstract

Related Papers

Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Manabu Soda, Young Lim Choi, Munehiro Enomoto et al.|Nature|2007|5.4k
Intragenic ERBB2 kinase mutations in tumours
Philip Stephens, Chris Hunter, Graham R. Bignell et al.|Nature|2004|790
The <i>EML4‐ALK</i> fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild‐type <i>EGFR</i> and <i>KRAS</i>
Daisy Wing‐Sze Wong, Elaine Lai‐Han Leung, Kimpton Kam‐Ting So et al.|Cancer|2009|722
Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer
Tetsuya Mitsudomi, Yasushi Yatabe|Cancer Science|2007|610
EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers
Kentaro Inamura, Kengo Takeuchi, Yuki Togashi et al.|Journal of Thoracic Oncology|2008|464